PharmaShots

JUNE 23, 2023

Gilead Receives EMA’s CHMP Positive Opinion of Trodelvy (sacituzumab govitecan) for Pre-Treated HR+/HER2- Metastatic Breast Cancer Date: June 23, 2023 | Tags: Gilead, Trodelvy, sacituzumab govitecan, HR+/HER2- Metastatic Breast Cancer, Regulatory, EMA, CHMP, Positive Opinion Sarepta Therapeutics’ Elevidys Receives the US FDA’s Accelerated (..)

Diabetes 40

Diabetes Biosimilars 40

PharmaShots

JUNE 16, 2023

Date: June 12, 2023 | Tags: Novartis, Chinook Therapeutics, Atrasentan, Zigakibart, BION-1301, IgA nephropathy, M&A, ~$3.5B Date: June 12, 2023 | Tags: Novartis, Chinook Therapeutics, Atrasentan, Zigakibart, BION-1301, IgA nephropathy, M&A, ~$3.5B

Diabetes 40

Diabetes Labelling 40

Fuld & Company Blog

MARCH 27, 2023

In fact, it was not until seven years later, in 2005, that Pfizer backtracked and received approval to launch sildenafil for its original cardiovascular purpose, under the brand Revatio. With trials showing potential weight loss of 10% to 15% , for many, the price tag of $1,500 per month is well worth it.

Diabetes 52

Diabetes Online Pharmacies Packaging Pharmaceutical Companies 52

pharmaphorum

FEBRUARY 26, 2021

Cordis was founded in Miami in 1959 and develops and produces medical equipment to treat patients who suffer from cardiovascular disease. For all the latest pharma news on Johnson & Johnson, follow pharmaphorum’s J&J and Janssen tags. CEO Alex Gorsky, who was appointed in 2012.

Vaccines 126

Vaccines Biosimilars Labelling Diabetes 126